Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA-Reference-Cited by-同舟云学术

Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA

Published:2011-07-20 Issue:8 Volume:22 Page:1673-1681
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Alam Md. Rowshon¹,Ming Xin²,Fisher Michael²,Lackey Jeremy G.¹,Rajeev Kallanthottathil G.¹,Manoharan Muthiah¹,Juliano Rudy L.²

Affiliation:

1. Alnylam Pharmaceuticals, 300 Third Street, Cambridge, Massachusetts 02142, United States

2. Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc200235q

Reference29 articles.

1. RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

2. 2-Modified Oligonucleotides for Antisense Therapeutics

3. Designing highly active siRNAs for therapeutic applications

4. A status report on RNAi therapeutics

5. Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro screening of chemically synthesized dipeptide-antisense oligonucleotide conjugates to identify ligand molecules enhancing their activity;Bioorganic & Medicinal Chemistry;2024-08

2. Perspective Chapter: Mastering RNA Interference (RNAi) Delivery – Strategies for Effective Targeting and Gene Silencing;Beyond the Blueprint - Decoding the Elegance of Gene Expression [Working Title];2024-07-12

3. Tuning of Ultrasmall Gold Nanoparticles Surface Properties Affect Their Biological Fate;Particle & Particle Systems Characterization;2024-06-04

4. LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo;Pharmaceutics;2024-04-17

5. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo;Nucleic Acids Research;2024-04-13